Source link : https://newshealth.biz/health-news/fda-panel-gives-thumbs-down-to-novel-strategy-for-switching-breast-cancer-therapy/
A novel strategy for switching breast cancer therapy intrigued members of an FDA advisory committee but failed to sway the panel to recommend approval of the strategy. By a 6-3 vote, the Oncologic Drugs Advisory Committee (ODAC) agreed with an FDA staff assessment that a randomized trial of the oral selective estrogen receptor degrader camizestrant […]
The post FDA Panel Gives Thumbs Down to Novel Strategy for Switching Breast Cancer Therapy first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-30 20:08:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8